Retrovirus meeting. HIV/AIDS researchers reach for high-hanging fruit.
Cohen
Jon
J
D016915:AIDS Vaccines; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018420:Ape Diseases / Q000453:epidemiology / Q000276:immunology / Q000821:virology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D015497:HIV-1 / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D009282:Naphthalenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use; D002679:Pan troglodytes; D011108:Polymers / Q000008:administration & dosage / Q000627:therapeutic use; D016097:Simian Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000276:immunology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000472:pathogenicity
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D009282:Naphthalenesulfonates; C120231:PRO 2000; D011108:Polymers